This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The University of British Columbia. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Casey Shannon - Innovator in Heart Transplantation Diagnostics
Introduction
Casey Shannon is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of heart transplantation through her innovative research and patented technologies. Her work focuses on improving the diagnosis of acute rejection in cardiac allografts, which is crucial for the success of heart transplant procedures.
Latest Patents
Casey Shannon holds a patent for "Biomarkers for the detection of acute rejection in heart transplantation." This patent outlines methods for diagnosing acute rejection using genomic expression profiling, proteomic expression profiling, or both. The techniques involve analyzing panels of nucleic acid markers and proteomic markers, providing a more accurate and timely diagnosis for patients undergoing heart transplants. She has 1 patent to her name.
Career Highlights
Shannon is affiliated with the University of British Columbia, where she conducts her research and collaborates with other experts in the field. Her work has garnered attention for its potential to enhance patient outcomes in heart transplantation.
Collaborations
Throughout her career, Casey has worked alongside notable colleagues such as Bruce McManus and Raymond Ng. Their collaborative efforts have contributed to advancements in the understanding and management of heart transplant rejection.
Conclusion
Casey Shannon's innovative work in the field of heart transplantation diagnostics exemplifies the impact of research and invention on medical practices. Her contributions are paving the way for improved patient care and outcomes in heart transplant procedures.